ABIONYX Pharma SA (EPA:ABNX)
France flag France · Delayed Price · Currency is EUR
1.840
+0.032 (1.77%)
Sep 11, 2026, 5:39 PM CET

ABIONYX Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7813441414868
Market Cap Growth
-37.86%223.58%-0.54%-14.37%-28.38%178.53%
Enterprise Value
7813439444963
Last Close Price
1.843.731.171.271.702.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-9.449.449.449.449.44
PS Ratio
19.1732.869.078.949.23100.22
PB Ratio
17.2729.595.495.246.766.34
P/TBV Ratio
--20.0216.8328.2212.95

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
19.2433.058.609.459.3193.31

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.840.840.370.430.560.46
Net Debt / Equity Ratio
0.060.06-0.06-0.090.00-0.28
Net Debt / EBITDA Ratio
-0.05-0.050.110.220.010.51
Net Debt / FCF Ratio
-0.09-0.090.130.190.010.43
Asset Turnover
0.310.310.320.300.280.04
Inventory Turnover
15.1515.1517.1621.8628.49-
Quick Ratio
0.990.991.491.681.391.86
Current Ratio
1.061.061.581.751.491.93
Return on Equity (ROE)
-92.29%-92.29%-56.76%-46.62%-47.14%-67.28%
Return on Assets (ROA)
-25.97%-25.97%-19.67%-13.91%-13.64%-23.16%
Return on Invested Capital (ROIC)
-115.47%-93.60%-62.69%-47.57%-55.39%-228.97%
Return on Capital Employed (ROCE)
-69.60%-69.60%-45.40%-31.30%-38.30%-39.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.12%-4.16%-10.62%-8.48%-8.68%-8.61%
FCF Yield
-4.08%-2.38%-8.97%-9.16%-7.27%-10.14%
Buyback Yield / Dilution
-3.73%-3.73%-14.80%-4.95%-12.41%-5.92%